Shares in Novo Nordisk climbed over five per cent on the Copenhagen exchange after the Danish pharmaceuticals firm received crucial approval from the United States Food and Drug Administration for
Pharmaceutical6- Page
192Articles
A major rise in the cost of Mounjaro is set to impact more than a million weight loss patients across Britain next month amid an international dispute over medicine prices.
Scientists at the Massachusetts Institute of Technology have harnessed artificial intelligence to design two innovative antibiotics capable of combating superbugs such as MRSA. This breakthrough could usher in a new
A new oral medication weight loss, orforglipron, has shown promising results in a landmark trial, marking a significant step for obesity treatment in the UK. Developed by Eli Lilly, orforglipron
Shares in European drug companies slumped to a four-month low on Wednesday, after US President Donald Trump reiterated his intention to impose tariffs on pharmaceutical imports in a bid to
Novo Nordisk, the Danish pharmaceutical titan known for its diabetes and weight loss treatments Ozempic and Wegovy, now faces a period of significant turbulence. The company has issued a stark
Alzheimers patients can extend cognitive health for years with breakthrough drugs ||| Groundbreaking trial results have revealed that radical new treatments can effectively stall the progression of Alzheimer’s disease for
AstraZeneca has reported record second quarter revenues, propelled by robust oncology sales and expansion in the United States, surpassing City expectations. The pharmaceutical company’s total revenue rose by 11 per
A breakthrough in the battle against Alzheimer’s disease may be on the horizon after promising trial results revealed the potential of an innovative drug developed by Roche. Trontinemab has delivered
AstraZenecas chief executive has described the pharmaceutical giant as a very American company following rising speculation about a potential shift of its main stock market listing from London to New
AstraZeneca has announced an ambitious plan to invest £50 billion in the United States by the end of the decade. This significant move is expected to bolster the company’s manufacturing
President Trump has escalated his efforts to encourage pharmaceutical companies to shift manufacturing to the United States by threatening to impose tariffs on the industry. He announced plans to introduce
The potential departure of AstraZeneca from the London Stock Exchange would deliver a ‘devastating blow’ to British markets, former Chancellor Lord Lamont warned Parliament today. The Conservative peer emphasised that
In a landmark transaction, US pharmaceutical behemoth Merck has secured the acquisition of London-based Verona Pharma for approximately $10 billion, marking a significant milestone in the biotech sector. The deal
WeightWatchers is embarking on a transformative journey following a significant debt restructuring, positioning itself to compete in the evolving landscape of weight management solutions. The company, which recently emerged from
Sir Pascal Soriot, the chief executive of AstraZeneca, Britain’s most valuable public company, has privately expressed his desire to relocate the pharmaceutical giant’s stock market listing to the United States,
